PetCaseFinder

Peer-reviewed veterinary case report

How lemon balm extract helps calm dogs

By Roy, Anne-Sophie et al.·Published in BMC veterinary research·2025·Nutrition, France·View original on PubMed

PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →

Original publication title: Metabolomics provides novel understanding of Melissa officinalis mechanism of action ensuring its calming effect on dogs.

Species:
dog
Behaviour & energyDogs

Plain-English summary

Twenty healthy beagle dogs were given different supplements to see how they affected behavior and stress levels. One group received a calming extract from the lemon balm plant (Melissa officinalis), while others got a placebo, a compound called rosmarinic acid, or a calming medication. After four weeks, the dogs that received the lemon balm extract showed significant improvements in their behavior compared to the placebo group. The study suggests that lemon balm may help reduce anxiety in dogs by affecting certain metabolic pathways.

People also search for: calming supplements for dogs · lemon balm for dog anxiety · beagle stress relief treatment

Abstract

BACKGROUND: Animal welfare encompasses both its physical and mental states. This latter could be altered by several psychological-related disorders including stress and anxiety. To address these issues, Melissa officinalis, a Lamiaceae plant, ensuring the anxiolytic-type effects, is widely used. In this study, the main aim was to explore the effect of a commercial hydro-alcoholic Melissa officinalis extract (MOE) and its major compound rosmarinic acid (RA) on dogs' behavior and metabolome. To do so, twenty healthy beagle dogs were randomly assigned to 4 dietary supplements (5 dogs/group): the first group received a placebo supplemented with maltodextrose (200 mg/kg), the second group was supplemented with MOE (200 mg/kg), the third group received RA at a dose of 10.6 mg/kg, and the fourth group was administered α-casozepine (AC) at a dose of 225 mg in capsule form. Dogs' behavior was monitored after 4 weeks of treatment using a standardized evaluation grid developed by Oniris. In addition, 4-hydroxybyturic acid (GHB) was quantified to study the effect of the supplementations on the metabolites of γ-aminobutyric acid (GABA) biosynthetic pathway. Moreover, the impact of all supplementations on dogs' metabolome was assessed using untargeted metabolomics at the end of the supplementation period. RESULTS: Results demonstrated significant differences between the mean behavioral score of placebo group (-3.4) compared to MOE (2.0), RA (1.4), and AC (0.8) groups. In addition, GHB measurement revealed a decrease in its quantity in all supplemented groups compared to the control. Moreover, untargeted metabolomics uncovered several metabolic pathways, that were impacted by MOE supplementation linked to lipids and bile acids metabolism. Furthermore, RA supplementation impacted fatty acids and lipids metabolism pathways while supplementation with AC affected pathways linked to lysine and sphingolipids metabolism. CONCLUSIONS: Our study demonstrated a calming effect of MOE on beagles and proposes a novel hypothesis that sheds new light on its potential mechanism of action. This study underlines metabolomics as an effective tool for gaining deep insights into the metabolic changes associated with supplementation.

Find similar cases for your pet

PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.

Search related cases →

Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/40646521/